Awaiting development: Guidance and quality standards

Skip to filters Skip to results

Showing 1 to 5 of 5

Type: GuidanceRemove Type: Guidance filter
Type: NICE adviceRemove Type: NICE advice filter
Guidance programme: Medical technologies guidanceRemove Guidance programme: Medical technologies guidance filter
Guidance programme: Highly specialised technologies guidanceRemove Guidance programme: Highly specialised technologies guidance filter
Guidance programme: Antimicrobial prescribing guidelinesRemove Guidance programme: Antimicrobial prescribing guidelines filter
Guidance programme: Cancer service guidelinesRemove Guidance programme: Cancer service guidelines filter
Guidance programme: Public health guidelinesRemove Guidance programme: Public health guidelines filter
Guidance programme: Social care guidelinesRemove Guidance programme: Social care guidelines filter

Guidance and quality standards awaiting development
Title	Type
Aquablation robotic therapy for lower urinary tract symptoms caused by benign prostatic hyperplasia	Medical technologies guidance
Doxecitine–doxribtimine for treating thymidine kinase 2 deficiency in people of any age who had symptoms before 13 years [ID6484]	Highly specialised technology
OTL-101 for treating adenosine deaminase deficiency–severe combined immunodeficiency [ID1152]	Highly specialised technology
Speedboat Inject for endoscopic submucosal dissection of lower gastrointestinal lesions	Medical technologies guidance
The Sonata Treatment - Transcervical Radiofrequency Fibroid Ablation using Intrauterine Ultrasound	Medical technologies guidance

Results per page

10
25
50
All